3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDIV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
24
Gastrointestinal
2
Thoracic
1
Gynecologic
1
CNS
1
Conditions
Lung Neoplasms
18
Carcinoma, Non-Small-Cell Lung
18
Breast Neoplasms
6
Small Cell Lung Carcinoma
5
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Colorectal Neoplasms
5
Mesothelioma, Malignant
4
Colonic Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Carcinoma, Renal Cell
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Neoplasm Metastasis
2
Mesothelioma
2
Melanoma
2
Kidney Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Hepatocellular
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Interventions
Docetaxel
19
pembrolizumab
14
Surveys and Questionnaires
7
Radiotherapy
7
Paclitaxel
7
Magnetic Resonance Spectroscopy
7
Gemcitabine
7
Standard of Care
6
Specimen Handling
6
Radiosurgery
6
Psychiatric Rehabilitation
6
Early Intervention, Educational
6
Trastuzumab
5
Nivolumab
5
enzalutamide
4
Interviews as Topic
4
motexafin gadolinium
3
cabozantinib
3
X-Rays
3
Sirolimus
3
Methods
3
Educational Status
3
Cisplatin
3
Carboplatin
3
Azacitidine
3
tisotumab vedotin
2
rucaparib
2
pertuzumab
2
pegilodecakin
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
sargramostim
×
Thoracic
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled